@SingularGenomic could be acquired by a deep-pocketed player, and they could come up with a NovaSeq-killer with that technology. This could be Thermo, Roche, but why not a young new contender like $TXG 10X Genomics?
@SingularGenomic could be acquired by a deep-pocketed player, and they could come up with a NovaSeq-killer with that technology. This could be Thermo, Roche, but why not a young new contender like $TXG 10X Genomics?